Higher-dose flu vaccine vs standard dose after lung transplant
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether a higher dose of flu vaccine works better than the standard dose for people who have had a lung transplant. It may help improve protection against seasonal flu while monitoring safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a lung transplant
- You are age 16 or older
- You are between 1 month and under 36 months after your lung transplant
- You can be contacted during the study by phone, email, or text
- You are expected to stay available for the whole study
- You have not had a serious allergic reaction to past flu vaccines or to egg/egg protein
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a high-dose flu vaccine to the standard dose in lung transplant recipients. It aims to see if a higher dose gives better protection against the flu.
This trial compares a higher-dose flu vaccine to the standard dose in children who recently received a kidney, heart, and/or liver transplant. It aims to see which dose better protects children against influenza while checking for safety.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This trial tests how well the flu vaccine works in people with blood cancers like lymphoma, leukemia, or multiple myeloma. It aims to find the best vaccination strategy to protect you during treatment.
This study looks at how your immune system (your body’s infection-fighting system) responds after you get the seasonal flu vaccine. It may help researchers understand what the vaccine triggers in people working in healthcare and labs.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
Hear when a new Immunization; Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.